Millennium Management Portfolio holdings
Millennium Management, founded in 1989 by Israel (Izzy) Englander and Ronald Shear and headquartered in New York City, is a global multi-strategy hedge fund managing over $71 billion in assets as of late 2024, employing a decentralized model with over 300 independent trading teams. Operating across equities, fixed income, commodities, currencies, and derivatives, the firm uses a mix of quantitative and fundamental strategies, providing its portfolio managers with capital, infrastructure, and autonomy to pursue diverse investment approaches while enforcing strict risk management. With more than 5,400 employees across offices in London, Hong Kong, Singapore, and beyond, Millennium has evolved from its initial $35 million seed capital—partly from the Belzberg family—into a titan of the hedge fund world, known for its ability to attract top talent and deliver consistent returns. Under Englander’s leadership as chairman and CEO, the firm remains a low-profile yet highly influential force in global finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$643M |
| 2 |
AT&T
T
|
+$311M |
| 3 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$306M |
| 4 |
Microsoft
MSFT
|
+$292M |
| 5 |
Ametek
AME
|
+$215M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$887M |
| 2 |
Apple
AAPL
|
+$694M |
| 3 |
PRAH
PRA Health Sciences, Inc.
PRAH
|
+$616M |
| 4 |
Amazon
AMZN
|
+$596M |
| 5 |
Linde
LIN
|
+$531M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.39% |
| 2 | Financials | 6.67% |
| 3 | Healthcare | 6.18% |
| 4 | Industrials | 4.97% |
| 5 | Consumer Discretionary | 4.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2601
CALL
US Bancorp
USB
$98.2B
| $6.06M | ﹤0.01% |
102,000
+25,600
| +34% | +$1.46M |
|
2602
BioCryst Pharmaceuticals
BCRX
$2.28B
| $6.06M | ﹤0.01% |
421,853
-293,287
| -41% | -$4.63M |
|
|
WPCA.U
2603
DELISTED
Warburg Pincus Capital Corporation I-A Units, each consisting of one Class A ordinary share, and one-fifth of one redeemable warrant
WPCA.U
| $6.06M | ﹤0.01% |
606,000
| – | – |
|
2604
Rush Enterprises Class A
RUSHA
$6.2B
| $6.06M | ﹤0.01% |
201,235
+73,818
| +58% | +$2.18M |
|
|
CHCT
2605
Community Healthcare Trust
CHCT
$523M
| $6.06M | ﹤0.01% |
134,063
+82,772
| +161% | +$4.01M |
|
2606
Dole
DOLE
$1.35B
| $6.05M | ﹤0.01% |
+356,944
| New | +$5.5M |
|
2607
iShares Silver Trust
SLV
$28B
| $6.05M | ﹤0.01% |
294,739
+179,399
| +156% | +$4.03M |
|
|
GSQD
2608
DELISTED
G Squared Ascend I Inc.
GSQD
| $6.05M | ﹤0.01% |
613,072
+64,766
| +12% | +$632K |
|
|
CRU
2609
DELISTED
Crucible Acquisition Corporation
CRU
| $6.04M | ﹤0.01% |
618,113
+302,623
| +96% | +$2.93M |
|
2610
CALL
argenx
ARGX
$53.4B
| $6.04M | ﹤0.01% |
+20,000
| New | +$6.34M |
|
2611
Edgewell Personal Care
EPC
$1.25B
| $6.03M | ﹤0.01% |
166,023
+141,898
| +588% | +$5.83M |
|
2612
PUT
DuPont de Nemours
DD
$18.5B
| $6.02M | ﹤0.01% |
70,585
+67,478
| +2,172% | +$6.25M |
|
2613
Mercer International
MERC
$42.3M
| $6.02M | ﹤0.01% |
519,325
-200,752
| -28% | -$2.33M |
|
2614
iShares US Transportation ETF
IYT
$2.26B
| $6M | ﹤0.01% |
98,728
+65,500
| +197% | +$4.14M |
|
|
TWCBU
2615
DELISTED
Bilander Acquisition Corp. Unit
TWCBU
| $6M | ﹤0.01% |
+600,000
| New | +$5.94M |
|
2616
EverQuote
EVER
$892M
| $6M | ﹤0.01% |
321,877
+217,312
| +208% | +$5.2M |
|
2617
Invesco S&P 500 Equal Weight ETF
RSP
$97B
| $5.99M | ﹤0.01% |
40,006
+6,263
| +19% | +$959K |
|
|
BTNB
2618
DELISTED
Bridgetown 2 Holdings Limited Class A Ordinary Shares
BTNB
| $5.99M | ﹤0.01% |
604,691
+159,460
| +36% | +$1.59M |
|
2619
iShares MSCI Singapore ETF
EWS
$1.04B
| $5.99M | ﹤0.01% |
262,912
+92,964
| +55% | +$2.16M |
|
2620
West Pharmaceutical
WST
$24B
| $5.98M | ﹤0.01% |
14,095
-7,062
| -33% | -$2.98M |
|
2621
Atmos Energy
ATO
$28.8B
| $5.97M | ﹤0.01% |
67,723
+61,387
| +969% | +$5.94M |
|
2622
Duke Energy
DUK
$97.8B
| $5.97M | ﹤0.01% |
61,206
+19,551
| +47% | +$2.02M |
|
2623
Pegasystems
PEGA
$5.02B
| $5.97M | ﹤0.01% |
93,912
+40,810
| +77% | +$2.72M |
|
|
STKL
2624
DELISTED
SunOpta
STKL
| $5.97M | ﹤0.01% |
667,966
-132,185
| -17% | -$1.34M |
|
2625
Alamos Gold
AGI
$11.6B
| $5.96M | ﹤0.01% |
827,474
+741,782
| +866% | +$5.71M |
|
Similar funds
Millennium Management's Q3 2021 Portfolio in Review
As of Q3 2021, Millennium Management held 7,698 positions worth $167B, up 2.3% from $163B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
Millennium Management deployed $8.65B of net new capital in Q3 2021, opening 1,244 new positions and adding to 2,720 existing holdings. Its largest new stake was Sight Sciences: 1,577,092 shares worth $35.8M.
By sector, the portfolio is most concentrated in Technology at 7.4% of assets, down from 7.8% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Apple, an estimated $694M trimmed.
- Millennium Management's largest Q3 2021 buy was Sight Sciences: 1,577,092 shares worth $35.8M.
- Millennium Management added most to State Street SPDR S&P 500 ETF Trust in Q3 2021, an estimated $643M increase.
- Millennium Management's biggest Q3 2021 reduction was Apple, cutting an estimated $694M.
- Millennium Management fully exited Alexion Pharmaceuticals in Q3 2021, selling an estimated $887M.
- Millennium Management's ten largest holdings make up 18% of its $167B portfolio in Q3 2021.
- Millennium Management opened 1,244 new positions and closed 981 in Q3 2021.
- Millennium Management's portfolio value rose 2.3% quarter-over-quarter to $167B.
Based on Millennium Management's 13F filing for Q3 2021, filed 15 Nov 2021.